A mathematical model of the kinetics and tissue distribution of 2-fluoro-β-alanine, the major catabolite of 5-fluorouracil

Zhang Ruiwen, Liu Tiepu, Soong Seng-Jaw, Robert B Diasio

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

2-Fluoro-ß-alanine (FBAL) is the major metabolite of 5-fluorouracil (FUra), one of the most widely used anticancer drugs. It has been suggested previously that FBAL and/or its metabolites may have a role in the hepatotoxidty, neurotoxicity and cardiotoxicity resulting from FUra chemotherapy. Studies in patients and experimental animals have demonstrated that FBAL has a prolonged elimination compared with the parent drug, FUra. In the present manuscript, a mathematical model is developed for the kinetics and tissue distribution of FBAL. This model is based on recently published data from a study of the pharmacokinetics and disposition of FBAL in rats (Zhang et al., Drug Metab Dispos 20: 113-119,1992). Satisfactory agreement was achieved between predicted and measured values, permitting an accurate evaluation of the kinetic and distribution parameters for FBAL. This model indicates that: (1) FBAL accumulates in several tissues including brain, heart, spleen, and enterohepatic system; and (2) enterohepatic circulation of FBAL and its bile add conjugates has an important role in FBAL kinetics and distribution as demonstrated by a model in which enterohepatic circulation parameters were deleted.

Original languageEnglish (US)
Pages (from-to)2063-2069
Number of pages7
JournalBiochemical Pharmacology
Volume45
Issue number10
DOIs
StatePublished - Apr 25 1993
Externally publishedYes

Fingerprint

Tissue Distribution
Fluorouracil
Alanine
Theoretical Models
Tissue
Mathematical models
Kinetics
Enterohepatic Circulation
Metabolites
Pharmaceutical Preparations
alpha-fluoro-beta-alanine
Pharmacokinetics
Chemotherapy
Manuscripts
Bile
Rats
Brain
Animals
Spleen
Parents

ASJC Scopus subject areas

  • Pharmacology

Cite this

A mathematical model of the kinetics and tissue distribution of 2-fluoro-β-alanine, the major catabolite of 5-fluorouracil. / Ruiwen, Zhang; Tiepu, Liu; Seng-Jaw, Soong; Diasio, Robert B.

In: Biochemical Pharmacology, Vol. 45, No. 10, 25.04.1993, p. 2063-2069.

Research output: Contribution to journalArticle

@article{9c8992fd70134f1eb0ee4b9fb80a2f3c,
title = "A mathematical model of the kinetics and tissue distribution of 2-fluoro-β-alanine, the major catabolite of 5-fluorouracil",
abstract = "2-Fluoro-{\ss}-alanine (FBAL) is the major metabolite of 5-fluorouracil (FUra), one of the most widely used anticancer drugs. It has been suggested previously that FBAL and/or its metabolites may have a role in the hepatotoxidty, neurotoxicity and cardiotoxicity resulting from FUra chemotherapy. Studies in patients and experimental animals have demonstrated that FBAL has a prolonged elimination compared with the parent drug, FUra. In the present manuscript, a mathematical model is developed for the kinetics and tissue distribution of FBAL. This model is based on recently published data from a study of the pharmacokinetics and disposition of FBAL in rats (Zhang et al., Drug Metab Dispos 20: 113-119,1992). Satisfactory agreement was achieved between predicted and measured values, permitting an accurate evaluation of the kinetic and distribution parameters for FBAL. This model indicates that: (1) FBAL accumulates in several tissues including brain, heart, spleen, and enterohepatic system; and (2) enterohepatic circulation of FBAL and its bile add conjugates has an important role in FBAL kinetics and distribution as demonstrated by a model in which enterohepatic circulation parameters were deleted.",
author = "Zhang Ruiwen and Liu Tiepu and Soong Seng-Jaw and Diasio, {Robert B}",
year = "1993",
month = "4",
day = "25",
doi = "10.1016/0006-2952(93)90017-Q",
language = "English (US)",
volume = "45",
pages = "2063--2069",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - A mathematical model of the kinetics and tissue distribution of 2-fluoro-β-alanine, the major catabolite of 5-fluorouracil

AU - Ruiwen, Zhang

AU - Tiepu, Liu

AU - Seng-Jaw, Soong

AU - Diasio, Robert B

PY - 1993/4/25

Y1 - 1993/4/25

N2 - 2-Fluoro-ß-alanine (FBAL) is the major metabolite of 5-fluorouracil (FUra), one of the most widely used anticancer drugs. It has been suggested previously that FBAL and/or its metabolites may have a role in the hepatotoxidty, neurotoxicity and cardiotoxicity resulting from FUra chemotherapy. Studies in patients and experimental animals have demonstrated that FBAL has a prolonged elimination compared with the parent drug, FUra. In the present manuscript, a mathematical model is developed for the kinetics and tissue distribution of FBAL. This model is based on recently published data from a study of the pharmacokinetics and disposition of FBAL in rats (Zhang et al., Drug Metab Dispos 20: 113-119,1992). Satisfactory agreement was achieved between predicted and measured values, permitting an accurate evaluation of the kinetic and distribution parameters for FBAL. This model indicates that: (1) FBAL accumulates in several tissues including brain, heart, spleen, and enterohepatic system; and (2) enterohepatic circulation of FBAL and its bile add conjugates has an important role in FBAL kinetics and distribution as demonstrated by a model in which enterohepatic circulation parameters were deleted.

AB - 2-Fluoro-ß-alanine (FBAL) is the major metabolite of 5-fluorouracil (FUra), one of the most widely used anticancer drugs. It has been suggested previously that FBAL and/or its metabolites may have a role in the hepatotoxidty, neurotoxicity and cardiotoxicity resulting from FUra chemotherapy. Studies in patients and experimental animals have demonstrated that FBAL has a prolonged elimination compared with the parent drug, FUra. In the present manuscript, a mathematical model is developed for the kinetics and tissue distribution of FBAL. This model is based on recently published data from a study of the pharmacokinetics and disposition of FBAL in rats (Zhang et al., Drug Metab Dispos 20: 113-119,1992). Satisfactory agreement was achieved between predicted and measured values, permitting an accurate evaluation of the kinetic and distribution parameters for FBAL. This model indicates that: (1) FBAL accumulates in several tissues including brain, heart, spleen, and enterohepatic system; and (2) enterohepatic circulation of FBAL and its bile add conjugates has an important role in FBAL kinetics and distribution as demonstrated by a model in which enterohepatic circulation parameters were deleted.

UR - http://www.scopus.com/inward/record.url?scp=0027288254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027288254&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(93)90017-Q

DO - 10.1016/0006-2952(93)90017-Q

M3 - Article

VL - 45

SP - 2063

EP - 2069

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 10

ER -